Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Nov 28, 2015 at 10:16 AM EST

4 Key FDA Decisions Expected By Year End

Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There…

Chris Lange | Nov 25, 2015 at 9:06 AM EST

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the short interest data on the top biotech companies.

Lee Jackson | Nov 24, 2015 at 10:47 AM EST

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the…

Jon C. Ogg | Nov 23, 2015 at 2:25 PM EST

Analysts Start MyoKardia With Positive Ratings

MyoKardia, Inc. (NASDAQ: MYOK) has now moved far enough beyond the October 28 IPO pricing that the analysts in the…

Jon C. Ogg | Nov 23, 2015 at 1:01 PM EST

Why Goldman Sachs Sees Serious Upside for Teva for 2016

Teva Pharmaceutical Industries Limited (NYSE: TEVA) had a very hard time getting off the ground from 2011 through the start…

Chris Lange | Nov 23, 2015 at 12:09 PM EST

Can-Fite Soars on Positive Phase 2 Developments

Biotech company Can-Fite announced development of its drug candidate CF102, which is currently in phase 2 trials for liver cancer,…

Chris Lange | Nov 23, 2015 at 9:00 AM EST

Mallinckrodt Impresses on Top and Bottom Line Results

Mallinckrodt PLC (NYSE: MNK) reported its fiscal fourth-quarter financial results before the markets opened on Monday. The company had $1.84…

Chris Lange | Nov 21, 2015 at 10:25 AM EST

6 BioHealth Movers That Now Cannot Be Ignored

24/7 Wall St. examines Valeant Pharmaceuticals and other biotech stocks with incredible gains or losses over the course of the…

Paul Ausick | Nov 21, 2015 at 9:15 AM EST

Biotech Industry Study Reports Big Gains in M&A, IPOs

Consulting firm BDO USA's "2015 BDO Biotech Briefing" examined recent annual report filings of stocks included on the Nasdaq Biotechnology…

Jon C. Ogg | Nov 20, 2015 at 11:05 AM EST

Anthem Affirms Guidance

Anthem is trying to convey the message that the problems of UnitedHealth Group are not its problem. At least that…

Lee Jackson | Nov 20, 2015 at 9:35 AM EST

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

A new Jefferies research report highlights four top companies that could be looking at catalysts that in the very near…

Chris Lange | Nov 19, 2015 at 12:15 PM EST

Axsome Therapeutics Quietly Enters Market in IPO

Axsome Therapeutics entered the market on Thursday morning at a price below the previously announced expected pricing range.

Chris Lange | Nov 19, 2015 at 12:10 PM EST

Celladon Soars on Proposed Merger Agreement

Celladon and Eiger BioPharmaceuticals have announced that they have entered into a definitive merger agreement.

Jon C. Ogg | Nov 19, 2015 at 11:50 AM EST

UnitedHealth Warning Creates Huge Spillover, With Big Implications Ahead

We have word from UnitedHealth Group in an earnings warning that could be a serious blow to at least part…

Chris Lange | Nov 19, 2015 at 10:15 AM EST

KaloBios Skyrockets After Martin Shkreli Takes a Majority Stake

Turing Pharmaceuticals CEO Martin Shkreli took a major stake in this small biopharma company KaloBios Pharmaceuticals over the course of…

1 … 233 234 235 236 237 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

4 Key FDA Decisions Expected By Year End

Short Sellers Run for Cover From Major Biotechs

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Analysts Start MyoKardia With Positive Ratings

Why Goldman Sachs Sees Serious Upside for Teva for 2016

Can-Fite Soars on Positive Phase 2 Developments

Mallinckrodt Impresses on Top and Bottom Line Results

6 BioHealth Movers That Now Cannot Be Ignored

Biotech Industry Study Reports Big Gains in M&A, IPOs

Anthem Affirms Guidance

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

Axsome Therapeutics Quietly Enters Market in IPO

Celladon Soars on Proposed Merger Agreement

UnitedHealth Warning Creates Huge Spillover, With Big Implications Ahead

KaloBios Skyrockets After Martin Shkreli Takes a Majority Stake

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Prospect Capital insiders are buying while yield hunters debate the safety

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Health and Healthcare Articles

All Health and Healthcare Articles

4 Key FDA Decisions Expected By Year End

Short Sellers Run for Cover From Major Biotechs

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Analysts Start MyoKardia With Positive Ratings

Why Goldman Sachs Sees Serious Upside for Teva for 2016

Can-Fite Soars on Positive Phase 2 Developments

Mallinckrodt Impresses on Top and Bottom Line Results

6 BioHealth Movers That Now Cannot Be Ignored

Biotech Industry Study Reports Big Gains in M&A, IPOs

Anthem Affirms Guidance

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

Axsome Therapeutics Quietly Enters Market in IPO

Celladon Soars on Proposed Merger Agreement

UnitedHealth Warning Creates Huge Spillover, With Big Implications Ahead

KaloBios Skyrockets After Martin Shkreli Takes a Majority Stake

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Prospect Capital insiders are buying while yield hunters debate the safety

Featured Reads

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70